Q32 Bio (QTTB) Institutional Ownership $2.19 -0.13 (-5.60%) Closing price 07/18/2025 04:00 PM EasternExtended Trading$2.21 +0.02 (+0.96%) As of 07/18/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Q32 Bio (NASDAQ:QTTB)CurrentInstitutional OwnershipPercentage31.32%Number ofInstitutional Buyers(last 12 months)40TotalInstitutional Inflows(last 12 months)$39.65MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$422.74K Get QTTB Insider Trade Alerts Want to know when executives and insiders are buying or selling Q32 Bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data QTTB Institutional Buying and Selling by Quarter Q32 Bio Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails6/27/2025Goldman Sachs Group Inc.44,373$73K0.0%+140.9%0.364% 5/21/2025Acadian Asset Management LLC31,138$50K0.0%N/A0.255% 5/16/2025Goldman Sachs Group Inc.44,373$73K0.0%+140.9%0.364% 5/16/2025AQR Capital Management LLC41,302$68K0.0%N/A0.339% 5/12/2025Nuveen LLC55,886$92K0.0%N/A0.458% 5/8/2025Monaco Asset Management SAM505,451$834K0.2%-12.1%4.144% 2/19/2025 Public Employees Retirement System of Ohio7,540$26K0.0%N/A0.062% 2/17/2025Squarepoint Ops LLC19,009$65K0.0%N/A0.156% 2/17/2025Two Sigma Investments LP53,175$183K0.0%N/A0.437% 2/17/2025Trustees of Columbia University in the City of New York133,903$461K0.1%N/A1.099% Get the Latest News and Ratings for QTTB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Q32 Bio and its competitors with MarketBeat's FREE daily newsletter. 2/17/2025Sanofi244,083$840K0.5%N/A2.004% 2/17/2025Millennium Management LLC10,725$37K0.0%-89.3%0.088% 2/17/2025Jacobs Levy Equity Management Inc.34,844$120K0.0%N/A0.286% 2/17/2025Deutsche Bank AG25,018$86K0.0%+699.8%0.205% 2/17/2025Cubist Systematic Strategies LLC12,249$42K0.0%N/A0.101% 2/17/2025Ameriprise Financial Inc.15,548$53K0.0%N/A0.128% 2/17/2025ArrowMark Colorado Holdings LLC81,482$280K0.0%N/A0.669% 2/17/2025Acorn Capital Advisors LLC803,425$2.76M1.5%N/A6.596% 2/13/2025Mariner LLC121,427$418K0.0%N/A0.997% 2/13/2025Townsquare Capital LLC17,466$60K0.0%N/A0.143% 2/13/2025Raymond James Financial Inc.10,746$37K0.0%N/A0.088% 2/11/2025AXQ Capital LP10,581$36K0.0%N/A0.087% 2/10/2025Monaco Asset Management SAM574,816$1.98M0.3%N/A4.719% 2/6/2025Raymond James Financial Inc.10,746$37K0.0%N/A0.088% 2/3/2025Hussman Strategic Advisors Inc.10,500$36K0.0%N/A0.086% 1/30/2025Rhumbline Advisers105,544$363K0.0%+1,164.3%0.867% 1/29/2025Savant Capital LLC15,281$53K0.0%N/A0.125% 1/27/2025Bleakley Financial Group LLC43,360$149K0.0%N/A0.356% 1/22/2025Drive Wealth Management LLC10,928$38K0.0%N/A0.090% 11/27/2024Franklin Resources Inc.4,857$225K0.0%N/A0.040% 11/19/2024Barclays PLC10,443$465K0.0%+105.2%0.086% 11/16/2024Geode Capital Management LLC131,768$5.88M0.0%+22.4%1.082% 11/15/2024Barclays PLC10,443$465K0.0%+105.2%0.086% 11/15/2024Jane Street Group LLC16,437$733K0.0%N/A0.135% 11/15/2024State Street Corp110,164$4.92M0.0%+35.5%0.904% 11/15/2024Point72 Asset Management L.P.76,685$3.42M0.0%N/A0.630% 11/14/2024Eventide Asset Management LLC190,000$8.48M0.1%N/A1.560% 11/14/2024MetLife Investment Management LLC3,563$159K0.0%N/A0.029% 11/13/2024BNP Paribas Financial Markets1,298$58K0.0%+199.1%0.011% 11/13/2024FMR LLC426,302$19.02M0.0%+137.3%3.500% Elon’s BIGGEST warning yet? (Ad)Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough. Click here to see why Tesla's about to prove everyone wrong... again.10/23/2024Values First Advisors Inc.741$33K0.0%N/A0.006% 8/13/2024Ensign Peak Advisors Inc64,481$1.16M0.0%+150.6%0.540% 8/9/2024Renaissance Technologies LLC14,764$265K0.0%N/A0.124% 8/9/2024Harvard Management Co. Inc.162,965$2.93M0.2%N/A1.365% 8/1/2024Rhumbline Advisers7,658$137K0.0%+11,681.5%0.064% 7/26/2024Bank of New York Mellon Corp17,569$315K0.0%N/A0.147% 5/17/2024Ikarian Capital LLC22,335$381K0.0%N/A0.685% 5/15/2024ARCH Venture Management LLC320,482$5.46M6.5%N/A9.831% 5/15/2024Affinity Asset Advisors LLC27,777$473K0.1%N/A0.852% 5/14/2024Platinum Investment Management Ltd.109,964$1.87M0.1%N/A3.373% 5/10/2024Acadian Asset Management LLC3,695$62K0.0%N/A0.113% 5/10/2024Vanguard Group Inc.107,752$1.84M0.0%N/A3.305% 5/6/2024Atlas Venture Life Science Advisors LLC2,092,106$35.65M3.3%N/A64.254% 5/3/2024Carlyle Group Inc.1,102,741$18.07M1.1%N/A33.826% 4/23/2024BML Capital Management LLC24,894$424K0.3%N/A0.764% 4/22/2024Vivo Capital LLC370,068$6.31M0.5%N/A11.366% (Data available from 1/1/2016 forward) QTTB Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of QTTB shares? During the previous two years, 50 institutional investors and hedge funds held shares of Q32 Bio. The most heavily invested institutionals were Atlas Venture Life Science Advisors LLC ($35.65M), FMR LLC ($19.02M), Carlyle Group Inc. ($18.07M), Eventide Asset Management LLC ($8.48M), Vivo Capital LLC ($6.31M), Geode Capital Management LLC ($5.88M), and ARCH Venture Management LLC ($5.46M).Learn more on Q32 Bio's institutional investors. What percentage of Q32 Bio's stock is owned by institutional investors? 31.32% of Q32 Bio's stock is owned by institutional investors. Learn more on QTTB's institutional investor holdings. Which institutional investors have been buying Q32 Bio's stock? Of the 49 institutional investors that purchased Q32 Bio's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Atlas Venture Life Science Advisors LLC ($2.09M), Carlyle Group Inc. ($1.10M), Acorn Capital Advisors LLC ($803.43K), Monaco Asset Management SAM ($574.82K), Vivo Capital LLC ($370.07K), ARCH Venture Management LLC ($320.48K), and FMR LLC ($246.66K). How much institutional buying is happening at Q32 Bio? Institutional investors have bought a total of 3,375,564 shares in the last 24 months. This purchase volume represents approximately $39.65M in transactions. Which of Q32 Bio's major shareholders have been selling company stock? The following institutional investors have sold Q32 Bio stock in the last 24 months: Millennium Management LLC ($89.62K), and Monaco Asset Management SAM ($69.37K). How much institutional selling is happening at Q32 Bio? Institutional investors have sold a total of 158,983 shares in the last 24 months. This volume of shares sold represents approximately $422.74K in transactions. Related Companies Acumen Pharmaceuticals Institutional Ownership Immunic Institutional Ownership Genenta Science Institutional Ownership VolitionRx Institutional Ownership Anebulo Pharmaceuticals Institutional Ownership Pyxis Oncology Institutional Ownership Adaptimmune Therapeutics Institutional Ownership Verrica Pharmaceuticals Institutional Ownership Connect Biopharma Institutional Ownership Sutro Biopharma Institutional Ownership This page (NASDAQ:QTTB) was last updated on 7/19/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Q32 Bio Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Q32 Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
